(Q35084820)

6 August 2017

1 reference

title

Gastroesophageal reflux disease during pregnancy. (English)

1 reference

gastroesophageal reflux disease

6 August 2017

0 references

author name string

Joel E Richter

series ordinal

1

1 reference

6 August 2017

1 March 2003

1 reference

Gastroenterology Clinics of North America

6 August 2017

1 reference

6 August 2017

32

1 reference

6 August 2017

1

1 reference

6 August 2017

235-261

1 reference

Pregnancy heartburn in Nigerians and Caucasians with theories about aetiology based on manometric recordings from the oesophagus and stomach.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

The gastro-œsophageal ‘sphincter’ and the mechanism of regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Reflux esophagitis as the cause of heartburn in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Determinants of pregnancy heartburn

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Heartburn in late pregnancy. Manometric studies of esophageal motor function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Observations on intragastric pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Evidence refuting a role for increased abdominal pressure in the pathogenesis of the heartburn associated with pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Effect of pregnancy on gastrointestinal transit

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Symptoms in gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

The safety and efficacy of gastrointestinal endoscopy during pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Treating gastro-oesophageal reflux disease during pregnancy and lactation: what are the safest therapy options?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Antacids. Indications and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Aluminum bioavailability and disposition in adult and immature rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Drug therapy: Cimetidine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Prenatal and neonatal exposure to cimetidine results in gonadal and sexual dysfunction in adult males.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Famotidine: summary of preclinical safety assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Endocrine effects of a new histamine H2-receptor antagonist, nizatidine (LY139037), in the male rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Fetal Effects of Metoclopramide Therapy for Nausea and Vomiting of Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Cisapride use during human pregnancy: a prospective, controlled multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Successful pregnancy in association with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Omeprazole for peptic ulcer disease in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

The safety of omeprazole during pregnancy: A multicenter prospective controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

The safety of proton pump inhibitors in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Placental transport of metoclopramide: Assessment of maternal and neonatal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Gastro-oesophageal reflux in pregnancy at term and after delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Narcotic analgesics and delayed gastric emptying during labour

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Cardiorespiratory studies in critical illness. Changes in aspiration pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Treatment of gastrointestinal motility disorders in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Comparison of cimetidine (Tagamet) with antacid for safety and effectiveness in reducing gastric acidity before elective cesarean section.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Effect of single-dose omeprazole on intragastric acidity and volume during obstetric anaesthesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

A comparison of omeprazole and ranitidine for prophylaxis against aspiration pneumonitis in emergency caesarean section.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Cimetidine excretion into breast milk

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Secretion of nizatidine into human breast milk after single and multiple doses

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

Omeprazole for refractory gastroesophageal reflux disease during pregnancy and lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900065-1

7 January 2021

10.1016/S0889-8553(02)00065-1

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12635418